Overview and Scope
Molecular modeling refers to the generation, representation, and/or manipulation of the three-dimensional structures of chemical and biological molecules and the determination of physicochemical attributes that can be used to understand the structural activity relationship (SAR) of the biological molecules. It involves using computer programs and mathematical algorithms to predict and visualize molecules' three-dimensional structure and properties.
Sizing and Forecast
The molecular modeling market size has grown rapidly in recent years. It will grow from $7.15 billion in 2023 to $8.25 billion in 2024 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to computational chemistry and molecular dynamics, early environmental and sustainability applications, enhanced visualization tools, increased use in enzyme and protein engineering, development of biomolecular modeling techniques..
The molecular modeling market size is expected to see rapid growth in the next few years. It will grow to $14.65 billion in 2028 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to integration of ai and machine learning algorithms, rise in drug discovery and development needs, expanding applications in material science, precision medicine and personalized treatment approaches, increasing utilization in virtual screening.. Major trends in the forecast period include advancements in computational power, ai and machine learning integration, growth in drug discovery and development, expansion in material science applications, focus on predictive medicine..
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/molecular-modeling-global-market-report
Segmentation & Regional Insights
The molecular modeling market covered in this report is segmented –
1) By Product: Software, Services
2) By Approach: Molecular Mechanics Approach, Quantum Chemistry Approach
3) By Application: Drug Development, Drug Discovery, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Research Centers And Academic Institutions, Other End Users
North America was the largest region in the molecular modeling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular modeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13272&type=smp
Major Driver Impacting Market Growth
The increasing drug development is expected to propel the growth of the molecular modeling market going forward. Drug development refers to discovering, designing, testing, and bringing new pharmaceutical compounds or medical treatments from the initial concept stage to regulatory approval and eventual market introduction. Molecular modeling plays a crucial role in various stages of drug development as it helps understand molecular interactions and evaluate the protein-ligand complex stability, functional reliability, and drug efficacy. For instance, in June 2023, according to the Accessibility Standards Canada, a Canada-based federal institution, there were 9,000 novel medications undergoing clinical trials in 2022, which is a notable increase from the approximately 8,500 drugs undergoing trials in 2021. Therefore, the increasing drug development is driving the growth of the molecular modeling market.
Key Industry Players
Major companies operating in the molecular modeling market report are Thermo Fisher Scientific Inc., BioNTech SE, Dassault Systemes SE, Bruker Corporation, Qiagen N.V., Physiomics plc, SilcsBio LLC, Compugen Ltd., Certara Inc., Schrödinger Inc., Jubilant Biosys Ltd., Simulations Plus Inc. , Genedata AG , Labvantage-Biomax GmbH, Acellera Ltd., Advanced Chemistry Development Inc., Molsoft L.L.C., Nimbus Therapeutics Inc., Crown Bioscience Inc., OTAVA Ltd., Chemical Computing Group, Molport SIA, Optibrium Ltd., BioSolveIT GmbH, Cyclica Inc., Cresset Group, Cyrus Biotechnology Inc., 3D Molecular Designs LLC, Inhibrx Inc., Leadscope Inc.
The molecular modeling market report table of contents includes:
1. Executive Summary
2. Molecular Modeling Market Characteristics
3. Molecular Modeling Market Trends And Strategies
4. Molecular Modeling Market - Macro Economic Scenario
5. Global Molecular Modeling Market Size and Growth
.
.
.
32. Global Molecular Modeling Market Competitive Benchmarking
33. Global Molecular Modeling Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Molecular Modeling Market
35. Molecular Modeling Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Currently, molecular modeling is invariably associated with computer modeling, where computational biology techniques are involved.
Molecular modeling has developed as a valuable and essential tool in various healthcare applications such as drug designing, drug development, and drug discovery processes.
Molecular modeling describes the generation, manipulation, or representation of three-dimensional structures of molecules and associated physicochemical properties.
The growth of the global molecular modeling market is attributed to the increasing investments in research and development by pharmaceutical and biotechnology companies, technological advancements in drug design, and increasing prevalence of various chronic diseases which increases the demand for drug development.
However, the high cost of research and development is restraining the growth of the market.
Key PlayersSimulations Plus, Inc., Chemical Computing Group, Certara, L.P, OpenEye Scientific Software, Dassault Systèmes, Cambridge Crystallographic Data Centre, Cresset, Acellera Ltd., Schrödinger, LLC, Optibrium, BioSolve-IT, and others Study objectivesTo provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global molecular modelling market.To provide insights into factors influencing and affecting the market growth.• To provide historical and forecast revenue of market segments and sub-segments with respect to countries.
